Psykedeliske stoffer i behandling av angst, depresjon og avhengighet
Tor-Morten Kvam, Lowan H. Stewart, Ole A. Andreassen
Tidsskrift for Den norske legeforening 2018 DOI: 10.4045/tidsskr.17.1110 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Gynecology |
| Citations | 15 |
| Key findings | Psychedelic substances show promise for treating mental disorders, but current evidence is limited by small study sizes and methodological issues. |
Abstract
Psykedeliske stoffer i behandling av flere psykiske lidelser har vist lovende resultater, men studiene er små og har metodologiske utfordringer. Det er behov for systematiske kliniske studier for å skaffe solid dokumentasjon for effekt og etablere rutiner for overvåkning av mulige bivirkninger.
Citations in the library
Cited by 4
- New Paradigms of Old Psychedelics in Schizophrenia Pharmaceuticals May 23, 2022
- Potential Therapeutic Effects of Psilocybin: A Systematic Review. Cureus October 1, 2022
- Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential. Cureus November 1, 2023
- Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for Psychiatrists Current Psychiatry Research and Reviews January 21, 2024
Cites 18
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
and 13 more in the library